FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103902 [Registered on: 16/02/2026] Trial Registered Prospectively
Last Modified On: 14/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare the effect of Saptamrita Lauha and Dhatri Lauha in Panduroga 
Scientific Title of Study   Comparative Clinical Evaluation of Saptamrita Lauha and Dhatri Lauha in Panduroga 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pratibha 
Designation  Post Graduate Scholar 
Affiliation  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway,Uttarakhand, India  
Address  OPD no. 13,14,Department of Kayachikitsa,Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway, Uttarakhand, India

Hardwar
UTTARANCHAL
249405
India 
Phone  8556869095  
Fax    
Email  pratibhabajaj2@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jyoti Arya 
Designation  Associate Professor  
Affiliation  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway, Uttarakhand, India  
Address  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway, Uttarakhand, India

Hardwar
UTTARANCHAL
249405
India 
Phone  9897942660  
Fax    
Email  drjyotiarya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jyoti Arya 
Designation  Associate professor  
Affiliation  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway,Uttarakhand, India 
Address  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway, Uttarakhand, India

Hardwar
UTTARANCHAL
249405
India 
Phone  9897942660  
Fax    
Email  drjyotiarya@gmail.com  
 
Source of Monetary or Material Support  
Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway, Uttarakhand, India 
 
Primary Sponsor  
Name  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan  
Address  Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Delhi Highway,Uttarakhand,India 249405 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pratibha  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan   Department of Kayachikitsa, OPD no.13/14,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar Delhi Highway, Uttarakhand 249405
Hardwar
UTTARANCHAL 
8556869095

pratibhabajaj2@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E611||Iron deficiency. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Saptamrit lauha , Reference: : Bhaishyajya Ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Honey ), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Dhatri lauha , Reference: Bhaishyajya Ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Honey ), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Male or females having classical symptoms of Panduroga.
Hb levels in males- 10gm%- 13gm% and in females- 8gm%- 11gm%.
Age 18 to 60 years.
Diagnosed patients without any complication.
Willingness to sign the consent form.

 
 
ExclusionCriteria 
Details  Pregnant and lactating women.
Hb levels less than 8gm%.
Malignancy, Kidney Disease, Thalassemia, Cardiac Disorders, Anemia due to any other causes other than Iron Deficiency.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in -
Panduta (pallor)
Hridayaspandan (palpitation)
Pindikodweshtana (cramps in calf region)
Aayasena shwasa (exertion dyspnoea)
Arochaka (anorexia )
Daurbalya (weakness) 
Day 30, Day 60 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in
HB levels
MCV
MCH
Reducing RDW 
Day 30, Day 60 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   25/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is double arm clinical evaluation of Saptamrita lauha and Dhatri lauha in Panduroga (Iron deficiency anemia).This will be conducted on 60 randomly selected patients from OPD of Kayachikitsa department of Patanjali Ayurved Hospital, Haridwar.
First follow up during treatment - 30 days and second follow up at the end of treatment i.e. 60 days. 
Assessment will be done on basis of subjective and objective parameters as discussed earlier.
 
Close